Inhibrx Biosciences Inc. (INBX) Earnings
NASDAQ·Healthcare·Biotechnology
$97.22
+9.72%
Mkt Cap $1.37B
EPS — Estimate vs Actual
Mkt Cap
$1.37B
P/E
—
Fwd P/E
—
P/S
1057.18
Rev TTM
—
EPS TTM
-$8.39
NASDAQ·Healthcare·Biotechnology
$97.22
+9.72%
Mkt Cap $1.37B
Mkt Cap
$1.37B
P/E
—
Fwd P/E
—
P/S
1057.18
Rev TTM
—
EPS TTM
-$8.39